Cojutti PGiorgio, Candoni A, Lazzarotto D, Rabassi N, Fanin R, Hope W, Pea F. Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with hematological malignancies. Br J Clin Pharmacol. 2018. Google ScholarPubMedLog in or register to post comments